These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 15666126
1. Ovariectomy fails to augment bone resorption and marrow B lymphopoiesis in granulocyte colony-stimulating factor transgenic mice. Oda T, Wada T, Kuwabara H, Sawada N, Yamashita T, Kokai Y. J Orthop Sci; 2005; 10(1):70-6. PubMed ID: 15666126 [Abstract] [Full Text] [Related]
2. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y. J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680 [Abstract] [Full Text] [Related]
3. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T. J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569 [Abstract] [Full Text] [Related]
4. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. Lee SK, Kalinowski JF, Jacquin C, Adams DJ, Gronowicz G, Lorenzo JA. J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384 [Abstract] [Full Text] [Related]
5. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T. Proc Natl Acad Sci U S A; 1997 Aug 19; 94(17):9360-5. PubMed ID: 9256487 [Abstract] [Full Text] [Related]
6. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T. J Clin Invest; 1994 Sep 19; 94(3):1090-7. PubMed ID: 8083350 [Abstract] [Full Text] [Related]
7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J. J Bone Miner Res; 2012 Jun 19; 27(6):1298-1308. PubMed ID: 22337253 [Abstract] [Full Text] [Related]
8. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. Shibata T, Shira-Ishi A, Sato T, Masaki T, Masuda A, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito MO, Ito M, Ogata E, Watanabe K, Ikeda K. J Bone Miner Res; 2002 Apr 19; 17(4):622-9. PubMed ID: 11918219 [Abstract] [Full Text] [Related]
10. In vivo administration of recombinant granulocyte-macrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis. Dorshkind K. J Immunol; 1991 Jun 15; 146(12):4204-8. PubMed ID: 2040797 [Abstract] [Full Text] [Related]
11. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6. Quesenberry PJ, McGrath HE, Williams ME, Robinson BE, Deacon DH, Clark S, Urdal D, McNiece IK. Exp Hematol; 1991 Jan 15; 19(1):35-41. PubMed ID: 1703492 [Abstract] [Full Text] [Related]
13. Ovariectomy-induced bone loss occurs independently of B cells. Li Y, Li A, Yang X, Weitzmann MN. J Cell Biochem; 2007 Apr 15; 100(6):1370-5. PubMed ID: 17131364 [Abstract] [Full Text] [Related]
16. RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice. Fujiwara Y, Piemontese M, Liu Y, Thostenson JD, Xiong J, O'Brien CA. J Biol Chem; 2016 Nov 25; 291(48):24838-24850. PubMed ID: 27733688 [Abstract] [Full Text] [Related]
17. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. Tyagi AM, Mansoori MN, Srivastava K, Khan MP, Kureel J, Dixit M, Shukla P, Trivedi R, Chattopadhyay N, Singh D. J Bone Miner Res; 2014 Sep 25; 29(9):1981-92. PubMed ID: 24677326 [Abstract] [Full Text] [Related]